Dispelix
Amount undisclosed
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Dispelix is currently valued at N/A as of November 18, 2025. The company has raised a total of $77.4M in funding.
Investment Perspective
Dispelix's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Dispelix Worth in 2025?
As of 2025, Dispelix is valued at N/A, based on the company's Merger/Acquisition funding round in November 18, 2025. This valuation positions Dispelix as one of the leading private companies in the sector.
Dispelix Valuation History
Dispelix's funding history demonstrates steady growth and investor confidence.
How Dispelix Valuation is Determined
Private company valuations like Dispelix's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Dispelix Valuation FAQs
Is Dispelix profitable?
Dispelix has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Dispelix's valuation compare to competitors?
Dispelix is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Dispelix IPO?
Dispelix has not announced plans for an initial public offering. Until an IPO, investors can access Dispelix shares through secondary market platforms.